Drug class
Antimicrosporidial antibiotic; methionine aminopeptidase-2 (MetAP2) inhibitor
Mechanism of action
Inhibits methionine aminopeptidase 2, an enzyme required for protein maturation and microsporidial proliferation. MetAP2 inhibition also accounts for antiangiogenic activity observed in other experimental settings.
General use cases
- Treatment of intestinal microsporidiosis caused by Enterocytozoon bieneusi in selected immunocompromised patients under specialist guidance.
- Topical compounded fumagillin has been used for ocular microsporidial infection; systemic and topical availability is limited and jurisdiction-specific.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
